JP Morgan Chase
CAMP icon

JP Morgan Chase’s CAMP4 Therapeutics CAMP Stock Holding History

JP Morgan Chase’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-238
Closed -$345 – 7416
2025
Q2 		$345 Sell
238
-8,005
-97% -$15.9K ﹤0.01% 6735
2025
Q1 		$33K Sell
8,243
-13,029
-61% -$63K ﹤0.01% 6010
2024
Q4 		$111K Buy
+21,272
New +$175K ﹤0.01% 5716

Other funds holding CAMP

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase's CAMP Position: Q3 2025 in Review

JP Morgan Chase sold out of CAMP4 Therapeutics (CAMP) in Q3 2025, closing a stake of 238 shares — an estimated $345 sold.

JP Morgan Chase first reported a position in CAMP in Q4 2024 and held it in 3 quarters. The position peaked at $111K in Q4 2024. 29 funds tracked by Wall St. Rank hold CAMP as of Q3 2025.

  • JP Morgan Chase reported no remaining CAMP4 Therapeutics position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 238 CAMP4 Therapeutics shares in Q3 2025, an estimated $345.
  • JP Morgan Chase first reported a position in CAMP4 Therapeutics in Q4 2024 and held it in 3 quarters.
  • JP Morgan Chase's CAMP4 Therapeutics position peaked at $111K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.